High-dose Mydocalm therapy in certain myogenous headaches.
Oral Mydocalm intermittent therapy was used in 113 patients suffering from myogenous cephalalgia. Daily 3 +/- 150 mg tolperisonum doses relieved, within 3-7 days, spasm, hypertonicity, rigidity of occipital, cervical, and shoulder muscles, and resulted in functional improvement and successfully controlled myogenous cephalalgias.
Csányi
L
L
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D005260:Female; D006261:Headache / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000150:complications*; D011427:Propiophenones / Q000627:therapeutic use*; D013315:Stress, Psychological / Q000150:complications; D014049:Tolperisone / Q000494:pharmacology / Q000627:therapeutic use*
D011427:Propiophenones; D014049:Tolperisone